|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Biosensors International Group Ltd
Main Activities: Miscellaneous Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Biosensors International Group Ltd Headquarters 31Kaki Bukit Road 3 #07-01/02 Techlink; Singapore; Singapore; 417818 Legal Address Clarendon House 2 Church Street; Singapore; Singapore; HM11 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : BMG113251000 Financial Auditors: Ernst & Young (2011) Incorporation Date: May 28, 1998 Total Employees: 312 Tel: (65) 6213 5777 |
|
Company Description |
| The Group develops, manufactures and commercialises innovative medical devices used in interventional cardiology and critical care procedures. The Group has internally developed technology to address each component of a drug-eluting stent system, including a stent,, a stent delivery catheter, a polymer and a proprietary drug. Biosensors is well-positioned to emerge as a leader in drugeluting stents and has developed a pipeline of next-generation products that are set to gain market share from traditional | ||
|
||
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the first quarter of 2013, total net operating revenues increased with 50.89%, from USD 60,803 thousands to USD 91,746 thousands. Operating result increased from USD 23,314 thousands to USD 34,906 thousands which means 49.72% change. The results of the period increased 44.66% reaching USD 32,632 thousands at the end of the period against USD 22,558 thousands last year. Return on equity (Net income/Total equity) went from 5.51% to 2.83%, the Return On Asset (Net income / Total Asset) went from 4.44% to 2.55% and the Net Profit Margin (Net Income/Net Sales) went from 37.10% to 35.57% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 11.31% compared to 24.00% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 6.00 to 4.29 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
| SELECT CURRENCY |
| Figures in: USD | EUR |
|
2013 Q3 (cons) |
2013 Q2C (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| WVB Company Financials | WVB Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
1,310,647 |
1,316,428 |
| ||
Current Assets |
471,539 |
497,929 |
| ||
Total Liabilities |
96,948 |
127,476 |
| ||
Shareholders Equity |
1,213,699 |
1,188,952 |
| ||
Current Liabilities |
54,343 |
104,381 |
| ||
| * All the accounts are in USD. | ||
Income Statement
| ||
Total Operating Revenue |
82,127 |
80,213 |
| ||
Operational Profit (Loss) |
24,438 |
28,434 |
| ||
Net Profit (Loss) |
24,941 |
28,159 |
| ||
| * All the accounts are in USD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
1.9% |
2.14% |
| ||
Annualised Return on Assets (ROA) |
7.6% |
4.28% |
| ||
Return on Equity (ROE) |
2.05% |
2.37% |
| ||
Annualised Return on Equity (ROE) |
8.2% |
4.74% |
| ||
Return on Sales (ROS) |
30.67% |
35.3% |
| ||
Return on Capital |
2.02% |
2.37% |
| ||
Gross Profit Margin |
85.79% |
85.88% |
| ||
Operating Profit Margin |
41.16% |
49.75% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
0.98x |
1.12x |
| ||
Inventory Turnover |
0.26x |
0.29x |
| ||
Current asset turnover |
0.17x |
0.16x |
| ||
Fixed-asset turnover |
0.10x |
0.10x |
| ||
Asset Turnover |
0.06x |
0.06x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
22,907 |
28,776 |
| ||
EBITDA |
28,653 |
34,604 |
| ||
Enterprise value |
789,326 |
743,576 |
| ||
Enterprise Value / EBITDA |
27.55 |
21.49 |
| ||
Bookvalue (BV) |
1,290,624 |
1,316,405 |
| ||
Net Cash |
277,439 |
266,857 |
| Liquidity Ratios | ||
| ||
Current Ratio |
867.71% |
477.03% |
| ||
Quick ratio |
786.53% |
439.59% |
| ||
Doom's day ratio |
610.53% |
355.66% |
| Leverage Ratios | ||
| ||
Leverage ratio |
107.99% |
110.72% |
| ||
Interest Coverage Ratio |
1,836.97% |
1,805.27% |
| ||
Debt to equity |
7.99% |
10.72% |
| ||
Debt to total assets |
7.4% |
9.68% |
| ||
Long Term Debt to Capital |
99.73% |
99.5% |
| ||
Debt / Enterprise Value |
2.54% |
0% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
38.43 |
32.22 |
| ||
Price/Book Ratio |
1.04 |
1.02 |
| ||
Market Cap / Net cash |
3.97 |
4.18 |
| ||
 |